These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 23102915)

  • 41. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J
    Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nop-7-associated 2 (NSA2), a candidate gene for diabetic nephropathy, is involved in the TGFβ1 pathway.
    Shahni R; Czajka A; Mankoo BS; Guvenel AK; King AJ; Malik AN
    Int J Biochem Cell Biol; 2013 Mar; 45(3):626-35. PubMed ID: 23220173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Non-Coding RNA and Diabetic Kidney Disease.
    Ren H; Wang Q
    DNA Cell Biol; 2021 Apr; 40(4):553-567. PubMed ID: 33733861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. microRNAs in Diabetic Kidney Disease.
    Chung AC
    Adv Exp Med Biol; 2015; 888():253-69. PubMed ID: 26663187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deciphering the role of MicroRNAs in diabetic nephropathy: Regulatory mechanisms and molecular insights.
    Abdelmaksoud NM; Al-Noshokaty TM; Abdelhamid R; Abdellatif N; Mansour A; Mohamed R; Mohamed AH; Khalil NAE; Abdelhamid SS; Mohsen A; Abdelaal H; Tawfik A; Elshaer SS
    Pathol Res Pract; 2024 Apr; 256():155237. PubMed ID: 38492358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions Among Non-Coding RNAs in Diabetic Nephropathy.
    Loganathan TS; Sulaiman SA; Abdul Murad NA; Shah SA; Abdul Gafor AH; Jamal R; Abdullah N
    Front Pharmacol; 2020; 11():191. PubMed ID: 32194418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic Mechanisms in Diabetic Kidney Disease.
    Thomas MC
    Curr Diab Rep; 2016 Mar; 16(3):31. PubMed ID: 26908156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epigenetic Regulations in Diabetic Nephropathy.
    Lu Z; Liu N; Wang F
    J Diabetes Res; 2017; 2017():7805058. PubMed ID: 28401169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
    Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
    J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long noncoding RNAs in the pathogenesis of diabetic kidney disease: implications for novel therapeutic strategies.
    Leti F; Morrison E; DiStefano JK
    Per Med; 2017 May; 14(3):271-278. PubMed ID: 29767584
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNAs in Podocyte Injury in Diabetic Nephropathy.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Ishibashi K; Morishita Y
    Front Genet; 2020; 11():993. PubMed ID: 33193581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Towards microRNA-based therapeutics for diabetic nephropathy.
    Alvarez ML; DiStefano JK
    Diabetologia; 2013 Mar; 56(3):444-56. PubMed ID: 23135222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Will the future lie in multitude? A critical appraisal of biomarker panel studies on prediction of diabetic kidney disease progression.
    Schutte E; Gansevoort RT; Benner J; Lutgers HL; Lambers Heerspink HJ
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv96-104. PubMed ID: 26209744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The possible role of glutathione-S-transferase activity in diabetic nephropathy.
    Tesauro M; Nisticò S; Noce A; Tarantino A; Marrone G; Costa A; Rovella V; Di Cola G; Campia U; Lauro D; Cardillo C; Di Daniele N
    Int J Immunopathol Pharmacol; 2015 Mar; 28(1):129-33. PubMed ID: 25816416
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New molecular insights in diabetic nephropathy.
    Checheriţă IA; Manda G; Hinescu ME; Peride I; Niculae A; Bîlha Ş; Grămăticu A; Voroneanu L; Covic A
    Int Urol Nephrol; 2016 Mar; 48(3):373-87. PubMed ID: 26759327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory cytokines in diabetic nephropathy.
    Donate-Correa J; Martín-Núñez E; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
    J Diabetes Res; 2015; 2015():948417. PubMed ID: 25785280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Noncoding RNAs in diabetes vascular complications.
    Beltrami C; Angelini TG; Emanueli C
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):42-50. PubMed ID: 25536178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.